TY - JOUR
T1 - Investigation of the Efficacy of an Intervention on Vancomycin Use in a Country with High Rate of Vancomycin Prescription
T2 - A Before-After Study
AU - Mohseni, Maryam
AU - Sheybani, Fereshte
AU - Eslami, Saeid
AU - Taherzadeh, Zhila
AU - Naderi, Hamidreza
AU - Yaddolahifar, Mohaddeseh
AU - Khosravi, Nasrin
AU - Tayefi, Maryam
N1 - Funding Information: From the *Faculty of Pharmacy; †Department of Infectious Diseases and Tropical Medicine, Faculty of Medicine; ‡Clinical Research Unit, Faculty of Medicine; §Pharmaceutical Research Center; ||Department of Medical Informatics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; ¶Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; and #Department of Pharmacodynamics and Toxicology, and **Center for Disease Control and Prevention, Mashhad University of Medical Sciences, Mashhad, Iran. The authors have no conflicts of interest to disclose. This research was conducted with funding support from the vice-chancellery for research of Mashhad University of Medical Sciences (Research Project Number 941764 and ethic IR.MUMS.fm.REC.1395.198 code). Mailing address: Department of Infectious Diseases and Tropical Medicine, Imam Reza Teaching Hospital, Daneshgah St, Mashhad, Iran. Correspondence to: Fereshte Sheybani, Department of Infectious Diseases and Tropical Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. E‐mail: Fereshtesheybani@gmail.com. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved. ISSN: 1056-9103 Publisher Copyright: © Wolters Kluwer Health, Inc. All rights reserved.
PY - 2020/9/1
Y1 - 2020/9/1
N2 - Objective The aim of the study was to investigate the efficacy of a reminder for the prescriber at the second key time of antimicrobial prescription on vancomycin use. Methods and Materials This study was conducted in a teaching hospital affiliated to Mashhad University of Medical Sciences, Iran, during a 6-month period. All hospitalized adult patients who received more than 48 hours of vancomycin were included and divided into an intervention and a non-intervention group. The intervention was a reminder to the prescriber in the form of a warning letter attached to the patient medical record at the second key time of the antibiotic prescription, emphasizing the microbiological test results. The primary outcome measure was the number of vancomycin days per patient. Results A total of 24,597 hospitalized adult patients were assessed for eligibility, of whom 1006 met the inclusion criteria. Overall, the rate of vancomycin prescription in preintervention period was 152.3 per 1000 hospitalized adult patients. In the post intervention period, the overall number of vancomycin days decreased significantly, with a reduction from 4342 to 1012 days in the intervention group that was equal to a decline of the mean of vancomycin days per patient from 10.9 to 8.9 days (P = 0.001). Conclusions Our study showed the effectiveness of an intervention in the form of a reminder at the second key time of antibiotic prescription in decreasing the overall number of vancomycin days and a mean of vancomycin days per patient. Despite this, there was still a high rate of overuse of vancomycin in the intervention group in postintervention period; a finding that emphasizes the importance and needs of root cause analysis of the factors associated with antibiotic prescription behaviors despite implementation of interventions in the future studies.
AB - Objective The aim of the study was to investigate the efficacy of a reminder for the prescriber at the second key time of antimicrobial prescription on vancomycin use. Methods and Materials This study was conducted in a teaching hospital affiliated to Mashhad University of Medical Sciences, Iran, during a 6-month period. All hospitalized adult patients who received more than 48 hours of vancomycin were included and divided into an intervention and a non-intervention group. The intervention was a reminder to the prescriber in the form of a warning letter attached to the patient medical record at the second key time of the antibiotic prescription, emphasizing the microbiological test results. The primary outcome measure was the number of vancomycin days per patient. Results A total of 24,597 hospitalized adult patients were assessed for eligibility, of whom 1006 met the inclusion criteria. Overall, the rate of vancomycin prescription in preintervention period was 152.3 per 1000 hospitalized adult patients. In the post intervention period, the overall number of vancomycin days decreased significantly, with a reduction from 4342 to 1012 days in the intervention group that was equal to a decline of the mean of vancomycin days per patient from 10.9 to 8.9 days (P = 0.001). Conclusions Our study showed the effectiveness of an intervention in the form of a reminder at the second key time of antibiotic prescription in decreasing the overall number of vancomycin days and a mean of vancomycin days per patient. Despite this, there was still a high rate of overuse of vancomycin in the intervention group in postintervention period; a finding that emphasizes the importance and needs of root cause analysis of the factors associated with antibiotic prescription behaviors despite implementation of interventions in the future studies.
KW - antibiotic resistance
KW - antimicrobial stewardship
KW - vancomycin
UR - http://www.scopus.com/inward/record.url?scp=85105552117&partnerID=8YFLogxK
U2 - https://doi.org/10.1097/IPC.0000000000000868
DO - https://doi.org/10.1097/IPC.0000000000000868
M3 - Article
SN - 1056-9103
VL - 28
SP - 281
EP - 284
JO - Infectious Diseases in Clinical Practice
JF - Infectious Diseases in Clinical Practice
IS - 5
ER -